August 15, 2025

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unveiling a 59.5% Potential Upside in the Biotechnology Arena

Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the biotechnology sector with its focus on developing innovative therapeutics for disorders related to dysfunctional signaling of the..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 124.59% Potential Upside in the Medical Device Sector

In the burgeoning field of medical devices, Butterfly Network, Inc. (NASDAQ: BFLY) stands out with its innovative approach to ultrasound imaging solutions. Despite the challenges faced..

Neuropace, Inc. (NPCE) Stock Analysis: Navigating an 85% Upside Potential

Neuropace, Inc. (NPCE), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its innovative contributions to the..

Investors Eye STAAR Surgical (STAA) Amid 55% Revenue Decline and High Forward P/E

STAAR Surgical Company (NASDAQ: STAA) has been a prominent name in the medical instruments and supplies industry for decades, with its innovative implantable lenses and laser-based..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 55% Potential Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with a potential upside of 55.32%, according to recent analyst ratings. As a clinical-stage..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 88% Upside in Biotech Innovation

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is capturing the attention of investors with its innovative approach to immunology-based therapies...

Claritev Corporation (CTEV) Stock Analysis: A Closer Look at its 3.97% Potential Upside

Claritev Corporation (CTEV), a prominent player in the healthcare sector, operates in the specialized niche of health information services. With a market capitalization of $1.12 billion,..

Community Health Systems, Inc. (CYH) Stock Analysis: Exploring a 33% Upside Potential

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, specifically within the medical care facilities industry, has been navigating a challenging market..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking a 171.74% Potential Upside in the Biotech Arena

For investors with a keen eye on the biotechnology sector, Nuvation Bio Inc. (NUVB) presents a compelling opportunity. Headquartered in New York, this clinical-stage biopharmaceutical company..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 271% Potential Upside in the Biotech Sector

Investors looking for promising opportunities in the biotechnology sector may want to take a closer look at Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). This American biotech company,..

Evolus, Inc. (EOLS) Stock Analysis: Aiming for a 196% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a notable player in the healthcare sector, is making waves in the drug manufacturing industry with its focus on specialty and generic..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 57.81% Potential Upside in the Health Information Services Sector

Weave Communications, Inc. (NYSE: WEAV), a prominent player in the health information services industry, is garnering attention from investors for its promising growth trajectory in the..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Potential 225% Upside in the Biotechnology Sector

Spyre Therapeutics, Inc. (NASDAQ: SYRE) has caught the attention of investors with its promising potential upside, pegged at an impressive 225.56%. As a clinical-stage biotechnology company,..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Deep Dive into Its Potential 142.91% Upside

Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its potential upside of..

CureVac N.V. (CVAC) Stock Analysis: Navigating the Biotechnology Landscape with mRNA Innovations

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, is at the forefront of mRNA-based therapeutic and vaccine development. With a current market capitalization..

GH Research PLC (GHRS) Stock Analysis: A Compelling 156.92% Upside for Biotech Investors

GH Research PLC (GHRS), a biotechnology firm headquartered in Dublin, Ireland, is capturing investor attention with its innovative approach to treating depression and its impressive potential..

Mind Medicine (MNMD) Stock Analysis: A 157% Potential Upside in the Biotech Sector

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) stands out in the competitive biotech sector with a compelling investment narrative. As a clinical-stage biopharmaceutical company, MindMed focuses on..

AnaptysBio, Inc. (ANAB) Stock Analysis: A Biotech with 127.84% Potential Upside

AnaptysBio, Inc. (NASDAQ: ANAB) is capturing attention in the biotech investment community with its compelling potential upside of 127.84%, making it a noteworthy candidate for investors..

Eton Pharmaceuticals, Inc. (ETON) Investor Outlook: Unveiling a Potential 79.64% Upside in the Rare Disease Market

Eton Pharmaceuticals, Inc. (ETON) stands out in the healthcare sector, particularly within the specialized realm of drug manufacturers focusing on rare diseases. With a market capitalization..

Simulations Plus, Inc. (SLP)

⚠️ No article content returned.

..
Search

Funds

August 15, 2025

Search

Funds

August 15, 2025

FTSE 100

Funds